1978 1980 1981 1982 1983 1984

1985 1986 1987 1988 1989 1990

1992 1993 1994 1995 1996 1997

1998 1999 2000 2001 2002 2003

2004 2005 2006 2007 2008

High-grade prostatic intraepithelial neoplasia.
Bostwick DG, Liu L, Brawer MK, Qian J.

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS.

Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").
Montironi R, Scattoni V, Mazzucchelli R, Lopez-Beltran A, Bostwick DG, Montorsi F.

Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E, Burzon D, Bostwick D, Steiner M.

Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL.

Prostate cancer detected by uPM3: radical prostatectomy findings.
Bostwick DG, Gould VE, Qian J, Susani M, Marberger M.

High grade prostatic intraepithelial neoplasia with squamous differentiation.
Melissari M, Lopez Beltran A, Mazzucchelli R, Froio E, Bostwick DG, Montironi R.

Atypical small acinar proliferation in the prostate: clinical significance in 2006.
Bostwick DG, Meiers I.

Prostate biopsy and optimization of cancer yield.
Bostwick DG, Meiers I.